首页 正文

The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors

{{output}}
Activation of tyrosine kinase receptors (TKRs) and their related pathways has been associated with development of endocrine tumors. Compounds that target and inactivate the kinase function of these receptors, tyrosine kinase inhibitors (TKIs), are now being ap... ...